Britain’s largest pharmaceutical companies have raised urgent concerns over what they describe as an “excessive” NHS sales rebate, warning it is harming investment in an economically crucial sector. Industry leaders
Britain’s largest pharmaceutical companies have raised urgent concerns over what they describe as an “excessive” NHS sales rebate, warning it is harming investment in an economically crucial sector. Industry leaders
Chancellor Rachel Reeves recently visited Siemens Healthineers in Oxford to present a vision for revitalising Britain’s economic growth. Highlighting the nation’s potential in areas such as artificial intelligence and life






